US Stock MarketDetailed Quotes

CARA Cara Therapeutics

Watchlist
  • 5.220
  • -0.140-2.61%
Close Jan 3 16:00 ET
  • 5.400
  • +0.180+3.45%
Post 20:01 ET
23.86MMarket Cap-0.25P/E (TTM)

Cara Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Cara Therapeutics Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 3 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2024/Q32.556M / 1.616M--
--2024/Q2991.000K / 1.174M--
May 13, 20242024/Q12.135M / 1.690M--
Mar 4, 20242023/Q43.004M / 9.135M--
Nov 13, 20232023/Q34.866M / 11.101M--
DatePeriodRevenue/EstimateEarnings Call
--2024/Q32.556M / 1.616M--
--2024/Q2991.000K / 1.174M--
May 13, 20242024/Q12.135M / 1.690M--
Mar 4, 20242023/Q43.004M / 9.135M--
Nov 13, 20232023/Q34.866M / 11.101M--

Unlock Free Earnings Estimates

Cara Therapeutics Earnings Reports

  • Cara Therapeutics | 10-Q: Q3 2024 Earnings Report

    Nov 14, 2024 16:17 ET

  • Cara Therapeutics | 10-Q: Q2 2024 Earnings Report

    Aug 14, 2024 16:16 ET

  • Cara Therapeutics | 10-Q: Q1 2024 Earnings Report

    May 13, 2024 16:20 ET

  • Cara Therapeutics | 8-K: Cara Therapeutics Reports First Quarter 2024 Financial Results

    May 13, 2024 16:15 ET

    • Read more

    Trending US Stocks
    Best Growth Stocks Best Growth Stocks

    Spot stocks with huge growth potential and solid financial standing. Spot stocks with huge growth potential and solid financial standing.

    Symbol Mini Chart % Chg
    DexCom
    DXCM
    +3.27%
    Collegium Pharmaceutical
    COLL
    +3.07%
    Lantheus
    LNTH
    +2.71%
    Cars.com
    CARS
    +1.72%
    YETI Holdings
    YETI
    +1.60%

    Unlock the Full List